ClinConnect ClinConnect Logo
Search / Trial NCT03886025

Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making

Launched by DR. NAJAT KHALIFA · Mar 20, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Transcranial Direct Current Stimulation (T Dcs) Decision Making Implusivity Brain Stimulation

ClinConnect Summary

This clinical trial is studying how a combination of brain stimulation (called tDCS) and cognitive training can improve decision-making and reduce impulsive behavior in people. The researchers want to see if this method helps people make better choices on a specific task called the Iowa Gambling Task and also helps with controlling impulsive actions. They believe that the combined treatment will lead to more positive outcomes than just using a placebo (a fake treatment).

To participate in this study, volunteers need to be between 18 and 40 years old and must be able to give their consent. However, individuals with conditions like epilepsy, certain neurological disorders, a history of serious head injury, substance misuse, major mental health issues, or those taking specific psychiatric medications cannot join. Participants can expect to take part in sessions involving brain stimulation and cognitive exercises, and they will be closely monitored throughout the trial. If you're interested in improving decision-making skills and reducing impulsivity, this trial might be a good opportunity for you.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consenting volunteers aged between 18 and 40.
  • Exclusion Criteria:
  • Individuals with epilepsy, other neurological conditions and history of significant head injury will be excluded.
  • Individuals with a history of substance misuse, major mental disorder and those receiving psychotropic medication will be also excluded.

About Dr. Najat Khalifa

Dr. Najat Khalifa is a distinguished clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive expertise in clinical trial design and implementation, Dr. Khalifa leads initiatives that focus on innovative therapies and evidence-based practices. Her collaborative approach fosters partnerships among healthcare professionals, regulatory bodies, and research institutions, ensuring the highest standards of compliance and ethical conduct in all trials. Dr. Khalifa is dedicated to facilitating groundbreaking studies that contribute to the development of novel treatments and enhance the understanding of various medical conditions.

Locations

Kingston, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Najat Khalifa, MD

Principal Investigator

Queen's University - Canada

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials